Literature DB >> 26110460

Subcutaneous administration of bovine superoxide dismutase protects lungs from radiation-induced lung injury.

Vlado Antonic1, Zahid N Rabbani2, Isabel L Jackson1, Zeljko Vujaskovic1.   

Abstract

BACKGROUND: The objective of the present study was to determine whether single administration of the antioxidant enzyme bovine superoxide dismutase (bSOD) after radiation therapy (RT) mitigates development of pulmonary toxicity in rats.
METHODS: Female F344 rats (n = 60) were divided among six experimental groups: (1) RT, single dose of 21 Gy to the right hemithorax; (2) RT + 5 mg/kg bSOD; (3) RT + 15 mg/kg bSOD; (4) No RT; (5) sham RT + 5 mg/kg bSOD; and (6) sham RT + 15 mg/kg bSOD. A single subcutaneous injection of bSOD (5 or 15 mg/kg) was administered 24 h post-radiation. The effects of bSOD on radiation-induced lung injury were assessed by measurement of body weight, breathing frequency, and histopathological changes. Immunohistochemistry was used to evaluate oxidative stress (8-OHdG(+), NOX4(+), nitrotyrosine(+), and 4HNE(+) cells), macrophage activation (ED1(+)), and expression of profibrotic transforming growth factor-β or TGF-β in irradiated tissue.
RESULTS: Radiation led to an increase in all the evaluated parameters. Treatment with 15 mg/kg bSOD significantly decreased levels of all the evaluated parameters including tissue damage and breathing frequency starting 6 weeks post-radiation. Animals treated with 5 mg/kg bSOD trended toward a suppression of radiation-induced lung damage but did not reach statistical significance.
CONCLUSIONS: The single application of bSOD (15 mg/kg) ameliorates radiation-induced lung injury through suppression of reactive oxygen species/reactive nitrogen species or ROS/RNS-dependent tissue damage.

Entities:  

Keywords:  bovine superoxide dismutase; fibrosis; radiation-induced lung injury; reactive oxygen species

Mesh:

Substances:

Year:  2015        PMID: 26110460      PMCID: PMC4874332          DOI: 10.3109/10715762.2015.1066501

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  55 in total

Review 1.  Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology.

Authors:  Søren M Bentzen
Journal:  Nat Rev Cancer       Date:  2006-09       Impact factor: 60.716

2.  Pharmacokinetics of superoxide dismutase in rats after oral administration.

Authors:  C Regnault; M Soursac; M Roch-Arveiller; E Postaire; G Hazebroucq
Journal:  Biopharm Drug Dispos       Date:  1996-03       Impact factor: 1.627

3.  Systemic polyethylene glycol-modified (PEGylated) superoxide dismutase and catalase mixture attenuates radiation pulmonary fibrosis in the C57/bl6 mouse.

Authors:  Mitchell Machtay; Arnaud Scherpereel; José Santiago; James Lee; Jim McDonough; Paul Kinniry; Evguenia Arguiri; Vladimir V Shuvaev; Jing Sun; Keith Cengel; Charalambos C Solomides; Melpo Christofidou-Solomidou
Journal:  Radiother Oncol       Date:  2006-10-27       Impact factor: 6.280

4.  Effect of superoxide dismutase on early radiation injury of lungs in the rat.

Authors:  K Malaker; R M Das
Journal:  Mol Cell Biochem       Date:  1988-12       Impact factor: 3.396

5.  Radiation-induced hypoxia may perpetuate late normal tissue injury.

Authors:  Z Vujaskovic; M S Anscher; Q F Feng; Z N Rabbani; K Amin; T S Samulski; M W Dewhirst; Z A Haroon
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-07-15       Impact factor: 7.038

6.  Overexpression of extracellular superoxide dismutase protects mice from radiation-induced lung injury.

Authors:  Song K Kang; Zahid N Rabbani; Rodney J Folz; Maria L Golson; Hong Huang; Daohai Yu; Thaddeus S Samulski; Mark W Dewhirst; Mitchell S Anscher; Zeljko Vujaskovic
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-11-15       Impact factor: 7.038

7.  Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase: clinical trial.

Authors:  S Delanian; F Baillet; J Huart; J L Lefaix; C Maulard; M Housset
Journal:  Radiother Oncol       Date:  1994-07       Impact factor: 6.280

8.  Successful treatment of radiation-induced fibrosis using Cu/Zn-SOD and Mn-SOD: an experimental study.

Authors:  J L Lefaix; S Delanian; J J Leplat; Y Tricaud; M Martin; A Nimrod; F Baillet; F Daburon
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-05-01       Impact factor: 7.038

9.  Effect of liposomal-encapsulated superoxide dismutase on active oxygen-related human disorders. A preliminary study.

Authors:  Y Niwa; K Somiya; A M Michelson; K Puget
Journal:  Free Radic Res Commun       Date:  1985

10.  Nox4 and redox signaling mediate TGF-β-induced endothelial cell apoptosis and phenotypic switch.

Authors:  F Yan; Y Wang; X Wu; H M Peshavariya; G J Dusting; M Zhang; F Jiang
Journal:  Cell Death Dis       Date:  2014-01-23       Impact factor: 8.469

View more
  4 in total

Review 1.  All for one, though not one for all: team players in normal tissue radiobiology.

Authors:  Marjan Boerma; Catherine M Davis; Isabel L Jackson; Dörthe Schaue; Jacqueline P Williams
Journal:  Int J Radiat Biol       Date:  2021-07-01       Impact factor: 2.694

2.  Rho inhibition by lovastatin affects apoptosis and DSB repair of primary human lung cells in vitro and lung tissue in vivo following fractionated irradiation.

Authors:  Verena Ziegler; Christian Henninger; Ioannis Simiantonakis; Marcel Buchholzer; Mohammad Reza Ahmadian; Wilfried Budach; Gerhard Fritz
Journal:  Cell Death Dis       Date:  2017-08-10       Impact factor: 8.469

3.  [Progression of Anti-oxygen Therapy in Radiation-Induced Lung Injury].

Authors:  Yingge Li; Qibin Song; Yi Yao; Yi Dong; Yanjun Gao; Bin Wu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2019-09-20

Review 4.  Superoxide Dismutase Administration: A Review of Proposed Human Uses.

Authors:  Arianna Carolina Rosa; Daniele Corsi; Niccolò Cavi; Natascia Bruni; Franco Dosio
Journal:  Molecules       Date:  2021-03-25       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.